Dipeptidyl Peptidase 4-Deficient Rats Have Improved Bile Secretory Function in High Fat Diet-Induced Steatosis

详细信息    查看全文

• 作者：Shani Ben Shlomo (1) (2)
  Isabel Zvibel (1) (2)
  Liane Rabinowich (1) (2)
  Ilana Goldiner (3)
  Amir Shlomai (1) (2)
  Erwin M. Santo (1) (2)
  Zamir Halpern (1) (2)
  Ran Oren (4)
  Sigal Fishman (1) (2) (5)
  
• 关键词：Bile secretory function ; Glucagon ; like peptide 1 ; Diet ; induced obesity ; Dipeptidyl peptidase 4 ; Bile acid synthesis ; Bile acid transporters
• 刊名：Digestive Diseases and Sciences
• 出版年：2013
• 出版时间：January 2013
• 年：2013
• 卷：58
• 期：1
• 页码：172-178
• 全文大小：323KB
• 参考文献：1. Baggio LL, Drucker DJ. Biology of incretins: GLP-1 and GIP. / Gastroenterology. 2007;132:2131-157. CrossRef
  2. Holst JJ. The physiology of glucagon-like peptide 1. / Physiol Rev. 2007;87:1409-439. CrossRef
  3. Ben-Shlomo S, Zvibel I, Shnell M, et al. Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase. / J Hepatol. 2011;54:1214-223. CrossRef
  4. Ding X, Saxena NK, Lin S, et al. Exendin-4, a glucagon-like protein-1 (GLP-1) receptor agonist, reverses hepatic steatosis in ob/ob mice. / Hepatology. 2006;43:173-81. CrossRef
  5. Li T, Kong X, Owsley E, et al. Insulin regulation of cholesterol 7 alpha-hydroxylase expression in human hepatocytes: roles of forkhead box O1 and sterol regulatory element-binding protein 1c. / J Biol Chem. 2006;281:28745-8754. CrossRef
  6. Pizarro M, Balasubramaniyan N, Solís N, et al. Bile secretory function in the obese Zucker rat: evidence of cholestasis and altered canalicular transport function. / Gut. 2004;53:1837-843. CrossRef
  7. Trauner M, Boyer JL. Bile salt transporters: molecular characterization, function, and regulation. / Physiol Rev. 2003;83:633-71.
  8. Trauner M, Arrese M, Soroka CJ, et al. The rat canalicular conjugate export pump (Mrp2) is down-regulated in intrahepatic and obstructive cholestasis. / Gastroenterology. 1997;113:255-64. CrossRef
  9. Trauner M, Arrese M, Lee H, et al. Endotoxin downregulates rat hepatic ntcp gene expression via decreased activity of critical transcription factors. / J Clin Invest. 1998;101:2092-100. CrossRef
  10. Thomas C, Gioiello A, Noriega L, et al. TGR5-mediated bile acid sensing controls glucose homeostasis. / Cell Metab. 2009;10:167-77. CrossRef
  11. Berry MN, Friend DS. High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structure study. / J Cell Biol. 1969;43:506-20. CrossRef
  12. Block GD, Locker J, Bowen WC, et al. Population expansion, clonal growth and specific differentiation patterns in primary cultures of hepatocytes induced by HGF/SF, EGF and TGF α in a chemically defined (HGM) medium. / J Cell Biol. 1996;132:1133-149. CrossRef
  13. Song KH, Chiang JY. Glucagon and cAMP inhibit cholesterol 7alpha-hydroxylase (CYP7A1) gene expression in human hepatocytes: discordant regulation of bile acid synthesis and gluconeogenesis. / Hepatology. 2006;43:117-25. CrossRef
  14. Lefebvre P, Cariou B, Lien F, et al. Role of bile acids and bile acid receptors in metabolic regulation. / Physiol Rev. 2009;89:147-91. CrossRef
  15. van Waarde WM, Verkade HJ, Wolters H, et al. Differential effects of streptozotocin-induced diabetes on expression of hepatic ABC-transporters in rats. / Gastroenterology. 2002;122:1842-852. CrossRef
  16. Li T, Chanda D, Zhang Y, et al. Glucose stimulates cholesterol 7 alpha-hydroxylase gene transcription in human hepatocytes. / J Lipid Res. 2010;51:832-42. CrossRef
  17. Goodwin B, Jones SA, Price RR, et al. A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis. / Mol Cell. 2000;6:517-26. CrossRef
  18. Donner MG, Keppler D. Up-regulation of basolateral multidrug resistance protein 3 (Mrp3) in cholestatic rat liver. / Hepatology. 2001;34:351-59. CrossRef
  19. Belinsky MG, Dawson PA, Shchaveleva I, et al. Analysis of the in vivo functions of Mrp3. / Mol Pharmacol. 2005;68:160-68.
  
• 作者单位：Shani Ben Shlomo (1) (2)
  Isabel Zvibel (1) (2)
  Liane Rabinowich (1) (2)
  Ilana Goldiner (3)
  Amir Shlomai (1) (2)
  Erwin M. Santo (1) (2)
  Zamir Halpern (1) (2)
  Ran Oren (4)
  Sigal Fishman (1) (2) (5)
  
  1. The Research Center for Digestive Tract and Liver Diseases, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
  2. The Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel
  3. Central Biochemistry Lab, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel
  4. Gastroenterology Institute, Hadassah Medical Center, Jerusalem, Israel
  5. Gastroenterology Department, Tel Aviv Sourasky Medical Center, 6 Weizmann, Tel Aviv, 64239, Israel
  
• ISSN：1573-2568

文摘

Background/Aims Rodent obesity models have been shown to display impaired bile secretory functions. We have shown that glucagon-like peptide 1 (GLP-1) attenuates hepatic lipogenesis, and in the present study we investigated whether GLP-1 also improves high fat diet-associated cholestatic injury. Methods Wild type (WT) and dipeptidyl peptidase 4-deficient rats (DPP4-) with chronic elevated serum levels of active GLP-1 were fed regular chow and a Western diet for 2?months. Primary hepatocytes were used to assess GLP-1 effects on mRNA expression and transcription of genes encoding bile acid synthesis enzymes and transporters. Results DPP4- exhibited attenuated liver injury as expressed by lower serum AST and ALT after 2?months of a Western diet. In addition, DPP4- had better insulin sensitivity, lower serum triglycerides, cholesterol and bile acids. Hepatic expression of cyp7A1, the rate limiting enzyme in conversion of cholesterol into bile acids, was strongly attenuated in DPP4- fed with a Western diet. Moreover, hepatic expression of bile transporter, ABCB11, was increased, facilitating a higher rate of bile secretion. Mechanistically, we showed that GLP-1 directly reduced basal and LXR-induced cyp7A1 mRNA expression and suppressed cyp7A1 transcription in transient transfection assays in primary hepatocytes. However, GLP-1 and its analog exendin 4 also induced mRNA expression of bile acid transporter ABCC3 in primary rat hepatocyte cultures. Conclusions Our data suggest that GLP-1 analogs may serve as a novel therapeutic drug to alleviate obesity-induced liver injury by reducing bile acid synthesis and improving liver bile secretory function.